Rubbert-Roth, A., Kakehasi, A. M., Takeuchi, T., Schmalzing, M., Palac, H., Coombs, D., . . . Curtis, J. R. (2023). Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis. Adis, Springer Healthcare.
Cita Chicago Style (17a ed.)Rubbert-Roth, Andrea, et al. Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis. Adis, Springer Healthcare, 2023.
Cita MLA (9a ed.)Rubbert-Roth, Andrea, et al. Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis. Adis, Springer Healthcare, 2023.